Incyte Corporation
INCY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 2.56 | 0.05 | -0.88 | 0.20 |
| FCF Yield | 3.28% | 0.19% | 2.24% | 2.54% |
| EV / EBITDA | 31.13 | 19.41 | 38.22 | 37.58 |
| Quality | ||||
| ROIC | 8.30% | 4.95% | 3.62% | 5.00% |
| Gross Margin | 92.75% | 92.13% | 91.49% | 91.08% |
| Cash Conversion Ratio | 1.32 | 0.11 | 1.68 | 1.89 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.07% | 9.28% | 8.34% | 7.70% |
| Free Cash Flow Growth | 2,021.95% | -90.24% | -27.74% | 24.10% |
| Safety | ||||
| Net Debt / EBITDA | -5.31 | -3.29 | -7.38 | -4.88 |
| Interest Coverage | 0.00 | 523.27 | 328.39 | 709.95 |
| Efficiency | ||||
| Inventory Turnover | 0.22 | 1.15 | 1.40 | 1.79 |
| Cash Conversion Cycle | -858.99 | -85.89 | -61.86 | -53.52 |